ALS (Amyotrophic Lateral Sclerosis) Patient Recruitment in North Carolina

TheraNovex connects clinical trial sponsors with pre-screened, eligible ALS (Amyotrophic Lateral Sclerosis) patients across North Carolina, including Charlotte, Raleigh, Greensboro, and beyond.

ALS clinical trial recruitment for familial, sporadic, and SOD1/C9orf72 mutation-positive studies.

Who qualifies: Adults with definite or probable ALS by El Escorial criteria, including SOD1, C9orf72, and FUS mutation carriers.

Recruitment challenges: Rapid disease progression and ALSFRS-R score eligibility require fast enrollment timelines.

Our approach: ALS clinic and MDA center networks, patient advocacy partnerships, and expedited enrollment workflows.

Our recruitment network spans all major metropolitan areas in North Carolina, ensuring broad geographic coverage for your ALS (Amyotrophic Lateral Sclerosis) trial.